Centrum 7/6  banner

AbbVie launches contest to support migraine patients

Print Friendly, PDF & Email

NORTH CHICAGO — AbbVie has announced the AbbVie Migraine Career Catalyst Award, a contest designed support migraine patients in the workplace. Twenty contest entrants will win up to $2,500 that they can decide to use toward career support, including career counseling, professional development programs, and networking opportunities.

Migraine is the world’s second leading cause of disability, impacting millions of people worldwide and nearly 40 million in the U.S. alone. “With the launch of the AbbVie Migraine Career Catalyst Award, we’re taking our commitment to the migraine community beyond the medicine and hoping to empower migraine patients to pursue their career goals with confidence,” said Jag Dosanjh, senior vice president, AbbVie, and president, neuroscience and eye care. “While migraine has a significant impact on many areas of life, including work, we are proud to support people living with the disease as they strive for migraine freedom.”

In the workplace specifically, recent findings from Chronic Migraine Epidemiology and Outcomes studies revealed that many migraine patients feel dismissed when expressing symptoms at work.

“Common migraine symptoms – including extra sensitivity to lights, sounds and smells, nausea, intense pain, difficulty thinking clearly and more – can make it difficult or impossible to work,” said Dr. Dawn Buse, clinical professor of neurology at Albert Einstein College of Medicine in New York City, fellow of the American Headache Society (AHS), and board member of the Headache Cooperative of the Pacific (HCOP).

Individuals living with migraine are invited to visit the contest website at www.migrainecareercatalyst.com and follow instructions to submit either (a) an essay not to exceed 3,000 characters in length, (b) a video up to three minutes in length, OR (c) an audio clip up to three minutes in length that describes their experience with migraine, their career goals, and how this award might help them in their career.

The submission period for the AbbVie Migraine Career Catalyst Award is now open and will close at 12:00 p.m. Eastern Time (ET) on Sept. 3, 2024. The winners will be announced on or about November 15, 2024. Please see full contest Official Rules at http://www.migrainecareercatalyst.com/.


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21